Skip to main content
Caplight Logo









Ubikare

Ubikare

Private
ErandioHealthcare & Life Scienceshttps://ubikare.io/

Last Round

Grant

Jan 28, 2022

Total Funding Raised

$1.63M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ubikare is a health-tech company that develops modular software solutions and the NAIHA (Natural & Artificial Intelligence Health Assistant) platform to optimize management and care in the healthcare and socio-health sectors.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Quantum Computing, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical data managementmedical AIhealthtechclinical decision supportquantum computingtelecarehealthcare analyticsclinical trialsSaaSsoftware medical devicedigital healthAI health assistantmedtechpatient coordinationAI in healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ubikare Comparables

Compare Ubikare with similar companies based on industry and business-model similarity.

Ubikare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dassault Systèmes
68%
Veeva Systems
65%
Castor
64%

Ubikare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 28, 2022
Corporate FundingSep 21, 2021
SeedJul 14, 2020
SeedJan 8, 2020

Key People

Founding team and executive leadership

Egoitz Arruti

CTO

Executive Team

Ubikare Investors

Notable investors and investment history

Ubikare investors
InvestorRounds
Seed Capital BizkaiaSeed
Mutua VenturesCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Partnered with Vicomtech and Multiverse Computing on Q-CLINIC initiative.

  • Apr 14, 2026

    Launched Q-CLINIC, applying quantum algorithms to clinical data management.

Recent news

Latest coverage and updates

  • partners_withJun 29, 2026

    ubikare.io, Inc. partnered with Ikerlan on Jun 29th '26.

Ubikare Filings

Explore SEC and related filing metadata, where available.

Ubikare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ubikare's valuation, stock price, and market status.

Is Ubikare a public or private company?

Ubikare is a private company.

What is the current stock price of Ubikare?

Ubikare is a private company with no public stock price. No recent secondary market data is available.

How much is Ubikare worth (valuation)?

Valuation information for Ubikare is not publicly available.

Can I buy Ubikare stock?

Ubikare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ubikare's last funding round?

Ubikare's most recent funding round was VC Round on January 28, 2022.

Who are the main investors in Ubikare?

Key investors in Ubikare include Seed Capital Bizkaia, Mutua Ventures.

Will Ubikare IPO soon?

No public IPO plans have been announced for Ubikare.

How can I track Ubikare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ubikare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersErandio
Employee Range26
Year Founded2016
Last FundingJan 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?